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Abstract
Background: Recently, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has become the rewarming
treatment of choice in hypothermic cardiac arrest. The detailed indications for extracorporeal rewarming in
non-arrested, severely hypothermic patients with circulatory instability have not been established yet. The primary
purpose of the study was a preliminary analysis of all aspects of the treatment process, as well as initial identification of
mortality risk factors within the group of severely hypothermic patients, treated with arteriovenous extracorporeal
membrane oxygenation (VA-ECMO). The secondary aim of the study was to evaluate efficacy of VA-ECMO in initial 6-h
period of treatment
Methods: From July 2013 to June 2016, thirty one hypothermic patients were accepted for extracorporeal rewarming
at Severe Accidental Hypothermia Center, Cracow. Thirteen patients were identified with circulatory instability and
were enrolled in the study. The evaluation took into account patients’ condition on admission, the course of therapy,
and changes in laboratory and hemodynamic parameters.
Results: Nine out of 13 analyzed patients survived (69%). Patients who died were older, had lower both systolic and
diastolic pressure, and had increased creatinine an potassium levels on admission. In surviving patients, arterial blood
gases parameters (pH, BE, HCO3) and lactates would normalize more quickly. Their potassium level was lower on
admission as well. The values of the core temperature on admission were comparable. Although normothermia was
achieved in 92% of patients, none of them had been weaned-off VA-ECMO in the first 6 h of treatment.
Discussion and Conclusions: In our preliminary study more pronounced markers of cardiocirculatory instability
and organ hypoperfusion were observed in non-survivors. Future studies on indications to extracorporeal
rewarming in severely hypothermic, non-arrested patients should focus on the extent of hemodynamic
disturbances. Short term (<6 h) treatment in severe hypothermic, non-arrested patients seems to be not clinically
appropriate.
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Background
The hypothermia-induced circulatory failure is multifactor-
ial. In the course of cooling dehydration, fluid shifts, and
increased urine output deplete the intravascular volume
and cause haemoconcentration. In severe hypothermia the
decrease in heart rate and rhythm disturbances result in fall
in cardiac output (CO). Systemic vascular resistance falls as
catecholamine release is blunted [1]. The further decrease
of cardiac output may result from cardiac contractile dys-
function [2]. During and after rewarming, a hypothermia-
induced cardiac failure ranging from mild reduction of CO
to the fulminant circulatory shock is referred to as rewarm-
ing shock [3].
Recently, veno-arterial extracorporeal membrane oxy-
genation (VA-ECMO) has become the rewarming treat-
ment of choice to be instituted in the presence of
hypothermic cardiac arrest or severe circulatory instabil-
ity [4–6]. One of the major advantages of VA-ECMO
seems to be possibility of prolonging cardiorespiratory
support if required after rewarming e.g. continuing cir-
culatory instability, arrhythmias or impaired tolerance
for the low-flow state [4, 7, 8].
Due to low availability of extracorporeal life support
(ECLS) equipment, few centers worldwide undertake
extracorporeal rewarming attempts in patients with acci-
dental hypothermia. One of the few such centers is
Severe Hypothermia Treatment Center (SHTC) estab-
lished in Cracow, Poland. Since all stages of diagnostics
and treatment have been based on the same original
protocol, there is a unique opportunity to conduct an
initial comparative data analysis of patients treated
under the same conditions in one center in a relatively
short period of time [9].
The use of ECLS for HT III patients (core temperature
<28 °C, not in cardiac arrest) may be considered in the
several situations [4], but the detailed indications for VA-
ECMO rewarming in this group of patients have not been
established yet. Thus, the primary aim of the study was a
preliminary analysis of all aspects of the treatment process,
as well as initial identification of mortality risk factors in
patients with cardiocirculatory instability in the course of
severe accidental hypothermia treated with VA-ECMO.
The secondary aim of the study was to evaluate efficacy
of VA-ECMO in initial 6-h of treatment, which – at least
in theory, taking into account achievable rate of rewarm-
ing, should allow for stabilization of core temperature and
cardiocirculatory disturbances.
Methods
From November 2013 to June 2016, 31 severely
hypothermic patients (core temperature < 28 °C) have
been rewarmed with VA-ECMO. Twelve of them ful-
filled the criteria of cardiocirculatory instability (systolic
blood pressure <90 mmHg and/or life-threatening
arrhythmia) [4, 5]. One patient was admitted with core
temperature 29,0 °C, but met all other clinical criteria of
inclusion. Two patients suffered from cardiac arrest
(ventricular fibrillation) during transport to the center,
but in both cases circulation had been restored after
short duration cardiopulmonary resuscitation (in 8th
and 15th minute). Therefore, 13 patients were included
in this study. Hypothermia was consecutive of urban ex-
posure in all patients.
Vascular access was obtained via the femoral artery and
vein with 22-24 Fr venous and 17-21 Fr arterial cannulas
(Bioline Coating, Maquet, Rastatt Germany). The Rotaflow
Console REF 706037 (Maquet, Rastatt, Germany) unit,
with Heat Unit HU 35 heat exchanger and oxygenator
(Permanent Life Support Set, Maquet, Rastatt, Germany)
was used in all cases.
The clinical characteristics of 13 analyzed patients in-
cluded: sex, age, type of exposure, type and distance of
transport, vital signs on arrival (heart rhythm, core
temperature, blood pressure, type of arrhythmia), compli-
cations during Intensive Care Unit (ICU) stay, catechol-
amine use (dose and duration of treatment), duration of
mechanical ventilation, duration of VA-ECMO treatment,
rate of rewarming, left ventricular ejection fraction (LVEF)
on discharge and survival rate. The clinical characteristics
of the group are presented in Table 1.
Comparison of clinical parameters between survivors
and non-survivors included core temperature (Tc), blood
pressure and end-tidal carbon dioxide (EtCO2) at admis-
sion, as well as parameters of acid-base balance (pH,
pCO2, pO2, base deficit), lactate level and clearance, serum
glucose, electrolytes and creatinine, levels of creatine kin-
ase, creatine kinase-MB and high sensivity troponin T
(hsTnT), hemoglobin level and coagulation profile.
Blood samples were collected for the blood glucose and
chemistry analysis at the time of admission and according
to accepted schedule. Arterial blood gas analysis according
to alpha-stat strategy (corrected to the normal body
temperature) was assessed on admission and on 2, 4, 6, 8,
10, 12, 16, 20, 24 h of ICU stay. Blood tests were assayed by
routine automated laboratory techniques (Cobas System
600, Roche Diagnostics GmbH, Manheim, Germany). All
biochemical analyses were performed in the central hospital
laboratory, certified with a cardiac and clinical chemistry
program by RIQAS (Randox Quality Assessment Scheme,
UK). Lactate clearance was calculated as followed [10]:
lactateinitial− lactatedelayed
 
=lactateinitial
  100%:
Due to a small sample included in the study, the stat-
istical analysis has been limited to presentation of de-
scriptive statistics. Categorical variables were presented
as numbers of subjects and percentages. Continuous
variables were analyzed for normal distribution using
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the Shapiro–Wilk test and were presented as mean plus
standard deviation and minimum and maximum for
normal distribution and were presented as median
values (Me) with lower and upper quartiles (IQR) for
non-normal distribution.
Results
The comparison of clinical parameters and outcomes of
survivors and non-survivors are presented in Table 2.
Patients who died were older, with lower blood pressure
and biochemical parameters abnormalities reflecting se-
vere organ hypoperfusion, including significantly in-
creased potassium level and more than doubled
creatinine concentrations. The clinical characteristics of
non-survivors, including time and cause of death are
presented in Table 3. In survivors, arterial blood gas pa-
rameters (pH, BE, HCO3
-) and lactates normalized fas-
ter. Lactate clearance in the first 24 h of ICU admission
is presented in Fig. 1. There is also a considerable differ-
ence between end-tidal CO2 and arterial blood gas CO2
partial pressure on admission of about 20 mmHg
(Table 2).
After 6 h of therapy, normothermia was achieved in
12 patients (92.3%). None of the patients had been
weaned off ECMO within the first 6 h of treatment. The
outcome of 13 patients after 6 h of VA-ECMO treatment
are presented in Table 4.
Discussion
In our study we have attempted to indicate unfavorable
prognostic factors in a small, but uniform group of se-
verely hypothermic patients with cardiocirculatory in-
stability, treated with VA-ECMO. Those factors were:
old age, low blood pressure on admission, low initial and
post-warming PaCO2 partial pressure, low pH, large base
deficit, high serum creatinine, potassium and lactate
levels (marked at least six hours of rewarming). How-
ever, the study sample size is too small to assess any pre-
dictive value of individual factors related to survival.
Thus, the main finding of the study is that most promin-
ent feature which distinguishes survivors and non-
survivors in our cohort are clinical and biochemical pa-
rameters reflecting organ hypoperfusion. At the moment
the clinical criteria to be considered as the indications
for ECLS rewarming are: failure to improve with exter-
nal active and minimally invasive rewarming methods,
life-threatening arrhythmia, hypotension (systolic blood
pressure <90 mmHg), respiratory failure, refractory
acidosis and comorbidities, which limit tolerance for
the low-flow state of HT III [4]. Although our study
was only observational in design and limited to small
number of patients it indicates, that future studies on
indications to extracorporeal rewarming in severely
hypothermic, non-arrested patients should focus on the
extent of hemodynamic disturbances. The mean sys-
tolic blood pressure in analyzed cohort was below
70 mmHg despite high catecholamine doses. Mair and
Ruttmann proposed a scheme in which the criteria for
introducing extracorporeal rewarming in non-arrested,
severely hypothermic patients was SBP ≤60 mmHg
Table 1 Characteristics and outcomes of the 13 patients in
severe accidental hypothermia with cardiocirculatory instability
Sex: Male 10 (77%)
Age [years] Me 60; IQR [56-66]
Urban-type hypothermia 13 (100%)
Distance of transport [km] Me 14, IQR [7-82]
Type of Transport
HEMS 2 (15%)
Ambulance 10 (77%)
ECMO team to the patient 1 (8%)
Tc on admission [°C] 25.8 ± 2.1 (20.7–29.0)
HR on admission [min-1] 53 ± 12.9 (40–80)
SBP [mmHg] Me 70 (50–80)
DBP [mmHg] Me 40 (30–60)
Heart rhythm on admission
Sinus rhythm 8 (62%)
Atrial fibrillation 2 (15%)
Junctional rhythm 3 (23%)
Complications during ICU stay
Aspiration Pneumonia 1 (8%)
Lower Limb Ischemia 3 (23%)
Bleeding from Upper GI Tract 3 (23%)
Alcohol Withdrawal Syndrome 4 (31%)
Kidney Failure 3 (23%)
Cathecholamine use
Adrenaline 4 (31%; mean dose
0.16 ug/kg/min)
Noradrenaline 9 (69%; mean dose
1.7 ug/kg/min)
Dopamine 2 (15%; mean dose
15 ug/kg/min)
Dobutamine 3 (23%; mean dose
16.7 ug/kg/min)
More than 1 cathecholamine used 5 (38%)
Cathecholamine administration [days] Me 2 IQR [1–7]
Duration of mechanical ventilation [days] Me 2 IQR [1,3–7,9]
Duration of VA-ECMO [hours] Me 23 IQR [19–32]
Rate of rewarming [C/hrs.] Me 1,8 IQR [1,5–3,0]
Duration of stay in the ICU [days] Me 3 IQR [2,0–9,0]
LVEF on discharge [%] 56 ± 8 (40–65)
Survived 9 (69%)
M denotes mean value; Me median, IQR interquartile interval
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Table 2 Characteristics of survivors and non-survivors
Parameter Survivors (n = 9) Non-survivors (n = 4)
Age [years] Me 57 IQR [55–60] Me 73 IQR [64.5–82.5]
Tc at hospital admission [°C] 26.07 ± 1.51 25.32 ± 3.24
SBP at hospital admission [mmHg] 74.4 ± 8.82 57.5 ± 5
DBP at hospital admission [mmHg] 47.2 ± 7.55 35 ± 5.77
pH at hospital admission 7.14 ± 0.08 7.02 ± 0.15
pH after achieving normothermia Me 7.32 IQR [7.32–7.33] Me 7.23 IQR [7.03–7.32]
EtCO2 at hospital admission 17.3 ± 1.5 14.5 ± 2.5
PaCO2 at hospital admission [mmHg] 41.4 ± 8.2 26.4 ± 7.4
PaCO2 after achieving normothermia [mmHg] Me 31.4 IQR [28.7–31.8] Me 24.5 IQR [19.2–29.6]
PaO2 at hospital admission [mmHg] 232.5 ± 117.7 107.6 ± 50.7
Lactate level (mmol/l) at hospital admission 6.89 ± 5.94 12.57 ± 4.55
Lactate level (mmol/l) after achieving normothermia Me 2.9 IQR [1.4–3.6] Me 12.2 IQR [8.4–15.3]
Lactate clearance 6 h 46.9% 5.7%
Lactate clearance 24 h 73.0% 34.8%
Lactate clearance at normothermia 56.0% 5.7%
BE at hospital admission [mEq/L] -14.322 ± 4.82 -23.45 ± 4.33
BE after achieving normothermia [mEq/L] Me -9.2 IQR [-11.4 – -7.7] Me -14 IQR [-22.1– -12.1]
HCO3 at hospital admission [mmol/L] 13.889 ± 4.09 7.225 ± 1.63
HCO3 after achieving normothermia [mmol/L] 16.389 ± 3.37 9.850 ± 4.78
K at hospital admission [mmol/L] 3.022 ± .76 4.975 ± .85
Na at hospital admission [mmol/L] 137.6 ± 6.4 143.2 ± 16.1
Glucose at hospital admission [mmol/L] 8.2 ± 2.97 6.1 ± 1.07
Creatinine at hospital admission [μmol/L] Me 85 IQR [64–114] Me 194 IQR [139-376]
CK at hospital admission [U/L] Me 1374 IQR [1114–2397] Me 4664 IQR [1724–18054]
CK 6 h [U/L] Me 1195 IQR [495–4168] Me 1948 IQR [595–6830]
CK-MB at hospital admission [U/L] Me 115 IQR [100–132] Me 278 IQR [164–394]
CK-MB 6 h [U/L] Me 70 IQR [54–183] Me 180 IQR [125-–249]
hsTnT at hospital admission [nmol/L] Me 0.033 IQR [0.027–0.048] Me 0.082 IQR [0.073–0.203]
hsTnT 6 h [nmol/L] Me 0.064 IQR [0.038–0.372] Me 0.097 IQR [0.091–0.17]
INR at hospital admission 1.46 ± .28 1.61 ± .23
APTT 0 h 37.7 ± 10.7 35.9 ± 15.1
PLT at hospital admission [103/uL] 142 ± 66 124 ± 110
Hb at hospital admission [g/dl] 12.13 ± 4.0 10.90 ± 3.66
Hb after achieving normothermia [g/dl] 9.54 ± 1.94 9.15 ± 1.21
Continuous data presented with mean value with standard deviation (normal distribution) or as median with lower and upper quartiles (non-normal distribution).
M denotes mean value; Me median, IQR interquartile interval
Table 3 The clinical characteristics of non-survivors
Sex/age (years) Tc (°C) VA ECMO treatment
(hours)
Time of death
(hours since admission)
Cause of death
M/66 20.7 42 216 gastrointestinal bleeding, hepatic failure, multiple organ failure
F/81 25.6 21 48 traumatic brain injury, gastrointestinal bleeding
M/63 27.0 26 36 methanol intoxication
F/84 28.0 16 20 gastrointestinal bleeding, renal insufficiency
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and/or serious rhythm disorders [11]. Taking into ac-
count the results of our study and experience from
SHTC, we were eager to accept those lower limits of
blood pressure instead of current <90 mmHg. At the
same time, in our opinion, there should be an emphasis
on acid-base balance parameters, which – if they are
not stabilized or normalized in the initial phase of
emergency actions – indicate serious hemodynamic dis-
turbances in the course of hypothermia.
Mortality rate until ICU discharge in our study was
31%. Vassal et al. in their study, which was also dedi-
cated to urban-type hypothermia, reported the mortality
rate of 38% with the core temperature (Tc) higher by 3 °
C, mean systolic pressure higher by 16 mmHg, and all
patients being rewarmed by non-invasive methods. Tak-
ing into account the study subgroup of patients with Tc
< 29 °C (21 patients), the mortality was over 50% [12].
When comparing the results of both studies it could be
concluded, that extracorporeal rewarming can be benefi-
cial, at least in selected group of the patients. However
despite numerous case reports, observation studies, rich
clinical experience and expert guidelines, there is lack of
randomized controlled trials and it is difficult to present
convincing, evidence-based proofs of increased survival
rate in patients treated by extracorporeal rewarming. In
many cases, death is caused by concomitant, chronic
conditions, trauma, and/or circumstances in which
hypothermia occurred (such as asphyxia in drowning or
avalanche burial) [4].
Ruttman et al. identified unfavorable prognostic fac-
tors in patients in cardiac arrest rewarmed with VA-
ECMO. A single-factor analysis indicated elevated level
of potassium, lower blood pH on admission, and pre-
ceding asphyxia as mortality factors [7]. In the whole
analyzed group, about 75% of patients were asphyxiated
due to drowning or avalanche burial. It is then possible,
that the results of electrolyte and acid-base abnormal-
ities did not reveal hypothermia per se, but were related
to asphyxia. However, in our cohort hypothermia was
induced by environmental exposure in urban setting in
all cases, without episodes of asphyxia. Thus, the re-
sults of our preliminary study correspond with the re-
sults obtained by Ruttman et al.
An additional objective of this study was to evaluate
the efficacy of the initial, 6-h period of VA-ECMO
rewarming. The median duration of extracorporeal treat-
ment in our group was 23 h and significantly exceeded
the time required for achieving normothermia. Even
within the group of survivors, after six hours of treat-
ment, the patients’ circulatory parameters were not
stable enough to safely wean-off VA-ECMO. The main
goals of the ECLS are stabilization of the core
Fig. 1 Individual patient lactate level profiles in first 24 h of ICU stay. Dots represent mean value of lactate level in all patients arterial blood
sample for the following hours. Bold lines represent smooth curve fitted by loess function with 95% confidence interval
Table 4 Outcome of 13 patients after 6 hours of VA-ECMO treatment
Feature Survivors Non-survivors Total
Normothermia 8/9 (88.9%) 4/4 (100%) 12/13 (92.3%)
Cathecholamine support (>1 drug) 7/9 (77.8%) 2/4 (50%) 9/13 (69.23%)
pH < 7.2 1/9 (11.1%) 2/4 (50%) 3/13 (23.07%)
Lack of lactate normalization 6/9 (66.7%) 4/4 (100%) 10/13 (76.92%)
Diuresis < 1 ml/kg/h 0/9 (0%) 2/4 (50%) 2/13 (15.4%)
Fluid resuscitation volume > 3000 ml/6 h 7/9 (77.8%) 4/4 (100%) 11/13 (84.6%)
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temperature and hemodynamic status, including cerebral
perfusion, particularly in patients after cardiac arrest [4,
11]. Prompt normalization of acid-base balance parame-
ters during the first six hours of VA-EMCO treatment
may be prognostically significant, and proves the treat-
ment to be effective, but is not clinically exhaustive.
Therefore, based on our data, it seems that the use of
short-term extracorporeal treatment of hypothermia, al-
though economically cost-effective, is clinically not
appropriate.
Severely hypothermic patients with cardiocirculatory
instability represent a vulnerable group of patients and it
is important to evaluate treatment strategies with inva-
sive techniques, as lack of randomized studies makes
causal inference of the benefit of such strategies uncer-
tain. However, our study has a number of limitations.
The small sample size affects the reliability of the find-
ings. There was no control group with which to compare
changes in parameters analyzed. The implementation of
a standardized approach makes the results from this co-
hort study more valid, but the findings need to be inter-
preted with caution.
Conclusions
In our preliminary study more pronounced markers of
cardiocirculatory instability and organ hypoperfusion
were observed in non-survivors. Future studies on indi-
cations to extracorporeal rewarming in severely
hypothermic, non-arrested patients should focus on the
extent of hemodynamic disturbances. In our opinion,
there should be an emphasis on acid-base balance pa-
rameters, which – if they are not stabilized or normal-
ized in the initial phase of emergency actions – indicate
serious hemodynamic disturbances in the course of
hypothermia. Short term (<6 h) extracorporeal treatment
in severe hypothermic, non-arrested patients seems to
be not clinically appropriate.
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